• Issue

    Journal of Viral Hepatitis: Volume 10, Issue 6

    405-478
    November 2003
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Review Article

Structure-based design of hepatitis C virus inhibitors

R. M. Smith,  G. Y. Wu, 
  • Pages: 405-412
  • First Published: 17 October 2003

Original Articles

Dynamics of hepatitis C virus quasispecies turnover during interferon-α treatment

M. von Wagner,  J.-H. Lee,  B. Rüster,  B. Kronenberger,  C. Sarrazin,  W. K. Roth,  S. Zeuzem, 
  • Pages: 413-422
  • First Published: 17 October 2003

A prospective study of blood alpha-fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis

M. Iavarone,  P. Lampertico,  G. Ronchi,  E. Del Ninno,  A. Zanella,  M. Colombo, 
  • Pages: 423-426
  • First Published: 17 October 2003

Hepatitis C virus proteins do not directly trigger fibrogenic events in cultured human liver myofibroblasts

K. Tan,  C. Guibert,  V. Neaud,  J. Rosenbaum, 
  • Pages: 427-432
  • First Published: 17 October 2003

Effects of hepatitis A vaccination on atherogenesis in a murine model

M. S. Burnett,  J. Zhu,  J. M. Miller,  S. E. Epstein, 
  • Pages: 433-436
  • First Published: 17 October 2003

Comparative study of the efficacy of an induction dose of interferon-α2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C

R. Pérez,  M. Jiménez,  J. Crespo,  M. Diago,  J. Enríquez,  P. Vaquero,  R. Solá,  J. L. Olcoz,  M. Romero,  J. Salmerón,  Mª I. Blanco,  Mª Oña,  S. Melón,  L. Rodrigo,  Grupo Inter-Hospitalario Español , 
  • Pages: 437-445
  • First Published: 17 October 2003

A serological study of intrafamilial spread from patients with sporadic hepatitis E virus infection

S. K. Somani,  R. Aggarwal,  S. R. Naik,  S. Srivastava,  S. Naik, 
  • Pages: 446-449
  • First Published: 17 October 2003

Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations

I. Raptis,  J. Koskinas,  T. Emmanouil,  S. Hadziyannis, 
  • Pages: 450-454
  • First Published: 17 October 2003

Occult hepatitis C virus infection in type II mixed cryoglobulinaemia

M. Casato,  D. Lilli,  G. Donato,  M. Granata,  V. Conti,  G. Del Giudice,  D. Rivanera,  C. Scagnolari,  G. Antonelli,  M. Fiorilli, 
  • Pages: 455-459
  • First Published: 17 October 2003

Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial *

H. Van Vlierberghe,  G. Leroux-Roels,  M. Adler,  N. Bourgeois,  F. Nevens,  Y. Horsmans,  J. Brouwer,  I. Colle,  J. Delwaide,  R. Brenard,  B. Bastens,  J. Henrion,  R. A. de Vries,  C. de Galocsy,  P. Michielsen,  G. Robaeys,  L. Bruckers, 
  • Pages: 460-466
  • First Published: 17 October 2003

Case Report

Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy

D. L. Sylvestre,  A. R. Disston,  D. P. Bui, 
  • Pages: 467-470
  • First Published: 17 October 2003

Index

Author index

  • Pages: 471-475
  • First Published: 17 October 2003

Subject index

  • Pages: 477-478
  • First Published: 17 October 2003